Viracta Therapeutics
VIRX
#10423
Rank
ยฃ0.62 M
Marketcap
ยฃ0.01572
Share price
-12.61%
Change (1 day)
-98.14%
Change (1 year)

Viracta Therapeutics (VIRX) - Cash on Hand

Cash on Hand as of September 2024 : ยฃ16.53 Million

According to Viracta Therapeutics's latest financial reports the company has ยฃ16.53 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Viracta Therapeutics - Cash on Hand chart (from 2020 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31ยฃ42.14 M-44%
2022-12-31ยฃ75.25 M-1.9%
2021-12-31ยฃ76.71 M122.07%
2020-12-31ยฃ34.54 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
ยฃ0.20 B 1,111.24%๐Ÿ‡บ๐Ÿ‡ธ USA